Ideas & Insights

Get yourself up to speed on the latest trends in private equity and mergers and acquisitions with the Q3 2019 CP Industry Spotlight.

Examine private equity deals, M&A trends and the economic implications of both in the newly released 2018 Annual B2B Industry Spotlight.

Examine PE deals, M&A trends and the economic implications of both in the newly released 2018 Annual HC & LS Industry Spotlight.

Examine private equity deals, M&A trends and the economic implications of both in the newly released 2018 Annual CP Industry Spotlight.

This fourth installment of the Powerhouses in private equity series features a candid conversation between RSM's Don Lipari and Jay Jordan.

RSM launches RSM launches M&A360™ An outcome-driven framework focused on enhancing value creation throughout the life of an investment

We are in the midst of a pandemic; RSM offers perspectives and insights on how COVID-19 has impacted middle market M&A.

Howard Morgan, co-founder of Argand Partners, is up close with RSM's Don Lipari to share his thoughts and insights on a vast set of topics.

Steve Klinsky, founder of New Mountain Capital, is up close with RSM's Don Lipari to share his thoughts and insights on an array of topics.

From deal difficulty to mega-fund success, Arsenal Capital Partners' Terrance Mullen is up close and personal with RSM's Don Lipari.

As PE firms are increasingly investing in healthcare businesses, what are the economics of such deals on doctors? Listen and learn.

A panel of private equity deal experts discuss the trends behind the deal statistics and outcomes from Q1 2018.

As software has grown exponentially as an industry, private capital has flowed into the sector in greater and greater amounts.

After a quiet period set off by the coronavirus pandemic, private equity deal activity in the United States surged through mid-November

Three veterans of the life sciences private equity and M&A market share intel about dramatic changes in the industry.

From the mega-deal void to a dip in private equity-backed exit activity, three middle market deal veterans compare notes on Q1 activity.

IPOs surge as valuation fatigue sets in: A panel of private equity deal experts discuss the trends behind the Q2 2019 numbers and outcomes.

An in-depth discussion addressing health care deals during COVID-19, the surge of telemedicine and the business of hospitals.

The latest trends in the private equity deal-making environment, including hot industry sectors and the future of exit activity.

The latest trends in the private equity deal-making market, including the Asia market, non-bank lenders and the void of U.S. mega deals.